Healthpeak Properties (DOC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Executive summary
Achieved strong operational and financial results in 2025, including $1.81 Nareit FFO per share, 4% same-store NOI growth, and a $1.22 annualized dividend, with a move to monthly payments.
Completed integration of Physicians Realty Trust merger and internalized property management, creating a $25 billion portfolio with 50 million sq. ft. of Outpatient Medical and Lab properties.
Announced the formation and planned IPO of Janus Living, a senior housing REIT, with Healthpeak retaining a majority interest post-IPO.
Board executed succession planning, appointing new CFO and General Counsel, and continued board refreshment with two directors retiring.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors, approval of 2025 executive compensation (say-on-pay), and ratification of Deloitte & Touche LLP as independent auditor for 2026.
Majority voting standard applies for director elections, with a director resignation policy for nominees not receiving majority support.
Proxy access allows groups of up to 25 shareholders owning at least 3% for three years to nominate up to 20% of the board.
Board of directors and corporate governance
Board consists of nine nominees, with a mix of tenures and diverse skills; all but two are independent.
Board leadership structure features an independent Chair; regular board and committee self-evaluations and refreshment, including a 15-year term limit policy.
Board committees (Audit, Compensation, Governance, Investment) are 100% independent, with annual rotation and high attendance.
Robust governance policies include codes of conduct, whistleblower hotline, anti-hedging/pledging, clawback, and stock ownership requirements.
Latest events from Healthpeak Properties
- Key votes include board elections, executive pay approval, and auditor ratification for 2026.DOC
Proxy Filing12 Mar 2026 - Janus Living IPO and operational efficiencies position Healthpeak for growth in core healthcare real estate.DOC
Citi’s Miami Global Property CEO Conference 20263 Mar 2026 - Janus Living IPO, $600M biotech campus acquisition, and $1B capital recycling drive growth.DOC
Investor presentation3 Mar 2026 - 2026 guidance anticipates a bottom in FFO, with growth expected as lab and senior housing recover.DOC
Q4 20253 Feb 2026 - Q2 net income surged, guidance raised, and $1.2B in asset sales completed.DOC
Q2 20242 Feb 2026 - Merger-driven scale, strong leasing, and robust financials support optimistic growth outlook.DOC
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong leasing, NOI growth, and higher guidance, fueled by merger synergies.DOC
Q3 202418 Jan 2026 - 2024 delivered strong growth and synergies, with 2025 set for continued investment and expansion.DOC
Q4 20248 Jan 2026 - Outpatient and life science platforms drive growth, with lab supply peaking and CCRC margins rising.DOC
Citi’s 30th Annual Global Property CEO Conference 20257 Jan 2026